Gene · 7026
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NR2F2 in cancer-associated fibroblasts drives immune microenvironment remodeling and promotes lung adenocarcinoma progression. | Front Immunol | 2026 | 42051516 | PubTator, text mining | PubMed |
| Nuclear receptor subfamily 2 group F member 2 transcriptionally activates 14-3-3 epsilon to promote diffuse large B-cell lymphoma progression. | Cytotechnology | 2026 | 42040327 | PubTator, text mining | PubMed |
| ASPP2 inhibits hepatocellular carcinoma growth by regulating cuproptosis via mitochondrial protein lipoylation. | Cell Death Dis | 2026 | 42031700 | PubTator, text mining | PubMed |
| miR-501-5p mediates the progression of type 2 diabetic retinopathy by targeting NR2F2. | Diabetol Metab Syndr | 2026 | 41957666 | PubTator, text mining | PubMed |
| Hells protects mitochondrial integrity via Nr2f2 suppression during osteoclast differentiation. | Cell Commun Signal | 2026 | 41947194 | PubTator, text mining | PubMed |
| A long-range enhancer at -52Kb drives expression of the COUP-TFII transcription factor in erythroid cells. | Sci Rep | 2026 | 41922632 | PubTator, text mining | PubMed |
| Establishing Area-Specific Brain Organoids Through Transcription Factor-Mediated Patterning. | Biology (Basel) | 2026 | 41892247 | PubTator, text mining | PubMed |
| NR2F2/AGAP2 axis: regulating lipid synthesis to drive AML progression via AMPKα/ACC pathway. | Cell Oncol (Dordr) | 2026 | 41838329 | PubTator, text mining | PubMed |
| The Heterogeneity and Function of Stromal Cells in the Tumor Microenvironment. | Research (Wash D C) | 2026 | 41809407 | PubTator, text mining | PubMed |
| Single-cell transcriptomic landscape of the mid-secretory eutopic endometrium reveals receptivity defects in adenomyosis. | J Transl Med | 2026 | 41787497 | PubTator, text mining | PubMed |
| Pathophysiology of androgen-associated endothelial cell dysfunction in phenotype A polycystic ovarian syndrome revealed by iPSCs modeling. | Front Endocrinol (Lausanne) | 2026 | 41767389 | PubTator, text mining | PubMed |
| Identification of multigene predictors of prognosis in patients with ovarian cancer. | iScience | 2026 | 41767263 | PubTator, text mining | PubMed |
| Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease. | J Clin Med | 2026 | 41753033 | PubTator, text mining | PubMed |
| A Single-Cell Perspective on Remapping Human Adult Neurogenesis and Its Clinical Implications. | Biomolecules | 2026 | 41750399 | PubTator, text mining | PubMed |
| COX7A1-mediated mitochondrial dysfunction can induce ferroptosis in endometrial cancer cells. | PLoS One | 2026 | 41729954 | PubTator, text mining | PubMed |
| Association of Increased Nasal Fluids-Serum Concordance of Protein Profile with Prognosis in Nasal Polyps. | J Inflamm Res | 2026 | 41717500 | PubTator, text mining | PubMed |
| The harmonies played by miR-302/367 cluster in pluripotency, reprogramming, and rejuvenation. | Stem Cells Transl Med | 2026 | 41693061 | PubTator, text mining | PubMed |
| Human Subcutaneous Derived Stromal Vascular Fraction Endothelial Cells Display Venous and Arterial Markers in Culture and 3D Capillaries. | Tissue Eng Regen Med | 2026 | 41670827 | PubTator, text mining | PubMed |
| Cross-dataset transcriptomic analyses identify a conserved ENPP2+ macrophage-fibroblast activation axis in hypertrophic cardiomyopathy. | Brief Bioinform | 2026 | 41642196 | PubTator, text mining | PubMed |
| Fast and flexible joint fine-mapping of multiple traits via the Sum of Single Effects model. | Nat Genet | 2026 | 41634413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7026/papers?page=2